XML 107 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended 17 Months Ended
Nov. 09, 2023
Aug. 07, 2023
Jan. 07, 2022
Nov. 15, 2021
Dec. 31, 2023
Oct. 31, 2023
Nov. 30, 2022
Dec. 31, 2023
Oct. 31, 2023
Jan. 07, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Jan. 31, 2024
Nov. 30, 2023
Jul. 31, 2023
Jan. 31, 2023
Oct. 31, 2021
Aug. 31, 2021
Nov. 30, 2018
May 31, 2015
Equity                                            
Shares of common stock authorized for issuance (in shares)         2,244,157     2,244,157     2,244,157                      
Repurchases of common stock                     $ 75,000 $ 14,063 $ 47,861                  
Assertio Therapeutics, Inc.                                            
Equity                                            
Number of warrants issued             40,666                              
Warrants outstanding         0     0     0                      
Third Amendment to the Nucynta Commercialization Agreement                                            
Equity                                            
Number of shares that can be purchased                                         1,041,667  
Exercise price of warrant (in dollars per share)                                         $ 19.20  
Prior Repurchase Program                                            
Equity                                            
Share repurchase program authorized amount                                     $ 100,000 $ 100,000    
Shares repurchased during the period                           3,235,823                
Repurchases of common stock                           $ 61,924                
Shares repurchased, cost per share                           $ 19.14                
2023 Repurchase Program                                            
Equity                                            
Share repurchase program authorized amount                               $ 100,000 $ 100,000          
Shares repurchased during the period                     3,088,069                      
Repurchases of common stock                     $ 75,000                      
Shares repurchased, cost per share                     $ 24.29                      
ASR                                            
Equity                                            
Share repurchase program authorized amount                               $ 25,000 $ 50,000   $ 25,000      
Price per share $ 23.11 $ 23.49   $ 19.48                                    
Shares repurchased during the period 865,426 1,702,852 307,132 1,026,694 57,349 462,442   922,775 2,165,294 1,333,826                        
Percentage of upfront payment on a price per share 80.00% 80.00%   80.00%                                    
Repurchases of common stock $ 25,000 $ 50,000   $ 25,000                                    
2014 Stock Incentive Plan                                            
Equity                                            
Shares of common stock authorized for issuance (in shares)                                           2,700,000
Increase in number of authorized shares on the first day of each fiscal year, as a percentage of outstanding common stock (as a percent)                     4.00%                      
Shares of common stock remaining available for future grant (in shares)         1,876,424     1,876,424     1,876,424                      
Vesting period (in years)                     4 years                      
Contractual life (in years)                     10 years                      
Minimum | 2014 Stock Incentive Plan                                            
Equity                                            
Period following termination date vested options are exercisable (in months)                     1 month                      
Maximum | 2023 Repurchase Program                                            
Equity                                            
Share repurchase program authorized amount                                   $ 100,000        
Maximum | 2014 Stock Incentive Plan                                            
Equity                                            
Period following termination date vested options are exercisable (in months)                     3 months                      
Subsequent Events | Maximum | 2024-2025 Repurchase Program                                            
Equity                                            
Share repurchase program authorized amount                             $ 150,000